Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
Simulations Plus (Nasdaq: SLP), a leader in cheminformatics, biosimulation, and medical communications for the biopharma industry, has announced its participation in the KeyBanc Capital Markets Virtual Healthcare Investor Forum.
CEO Shawn O'Connor will engage in a fireside chat on Tuesday, March 18, 2025, at 2:15 p.m. Eastern Time. The event will include one-on-one meetings with institutional investors throughout the day. Interested parties can access the fireside chat through a live webcast, which will be available on the Simulations Plus website's Investors page for approximately 90 days after the event.
Simulations Plus (Nasdaq: SLP), un leader nel campo della cheminformatica, biosimulazione e comunicazioni mediche per l'industria biofarmaceutica, ha annunciato la sua partecipazione al KeyBanc Capital Markets Virtual Healthcare Investor Forum.
Il CEO Shawn O'Connor parteciperà a una chiacchierata informale il martedì 18 marzo 2025, alle 14:15 ora orientale. L'evento includerà incontri individuali con investitori istituzionali durante tutta la giornata. Le parti interessate potranno accedere alla chiacchierata informale tramite una trasmissione in diretta, che sarà disponibile sulla pagina Investitori del sito web di Simulations Plus per circa 90 giorni dopo l'evento.
Simulations Plus (Nasdaq: SLP), un líder en quimioinformática, biosimulación y comunicaciones médicas para la industria biofarmacéutica, ha anunciado su participación en el KeyBanc Capital Markets Virtual Healthcare Investor Forum.
El CEO Shawn O'Connor participará en una charla informal el martes 18 de marzo de 2025, a las 2:15 p.m. hora del este. El evento incluirá reuniones uno a uno con inversores institucionales durante todo el día. Las partes interesadas podrán acceder a la charla informal a través de una transmisión en vivo, que estará disponible en la página de Inversores del sitio web de Simulations Plus durante aproximadamente 90 días después del evento.
Simulations Plus (Nasdaq: SLP), 생화학 정보학, 바이오 시뮬레이션 및 의료 커뮤니케이션 분야의 선두주자로, KeyBanc Capital Markets Virtual Healthcare Investor Forum에 참여한다고 발표했습니다.
CEO Shawn O'Connor는 2025년 3월 18일 화요일, 동부 표준시 오후 2시 15분에 화기애애한 대화에 참여할 예정입니다. 이 행사에서는 하루 종일 기관 투자자와의 1:1 미팅이 포함됩니다. 관심 있는 분들은 이벤트 후 약 90일 동안 Simulations Plus 웹사이트의 투자자 페이지에서 생중계로 화기애애한 대화를 시청할 수 있습니다.
Simulations Plus (Nasdaq: SLP), un leader dans le domaine de la chimiométrie, de la biosimulation et de la communication médicale pour l'industrie biopharmaceutique, a annoncé sa participation au KeyBanc Capital Markets Virtual Healthcare Investor Forum.
Le PDG Shawn O'Connor participera à une discussion informelle le mardi 18 mars 2025, à 14h15 heure de l'Est. L'événement comprendra des réunions individuelles avec des investisseurs institutionnels tout au long de la journée. Les parties intéressées pourront accéder à la discussion informelle via un webinaire en direct, qui sera disponible sur la page Investisseurs du site Web de Simulations Plus pendant environ 90 jours après l'événement.
Simulations Plus (Nasdaq: SLP), ein führendes Unternehmen in der Chemoinformatik, Biosimulation und medizinischen Kommunikation für die Biopharma-Industrie, hat seine Teilnahme am KeyBanc Capital Markets Virtual Healthcare Investor Forum angekündigt.
CEO Shawn O'Connor wird am Dienstag, den 18. März 2025, um 14:15 Uhr Eastern Time an einem informellen Gespräch teilnehmen. Die Veranstaltung umfasst ganztägige Einzelgespräche mit institutionellen Investoren. Interessierte Parteien können über einen Live-Stream auf die informelle Unterhaltung zugreifen, die etwa 90 Tage nach der Veranstaltung auf der Investoren-Seite der Simulations Plus-Website verfügbar sein wird.
- None.
- None.
A live webcast of the fireside chat can be accessed via this link and also on the Investors page of the Simulations Plus website where it will be available for replay for approximately 90 days following the event.
About Simulations Plus, Inc.
With more than 25 years of experience serving clients globally, Simulations Plus stands as a premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. Our comprehensive biosimulation solutions integrate artificial intelligence/machine learning (AI/ML), physiologically based pharmacokinetics, physiologically based biopharmaceutics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. We also deliver simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Our cutting-edge technology is licensed and utilized by leading pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our 2023 ESG update.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250310666294/en/
Financial Profiles
Lisa Fortuna
310-622-8251
slp@finprofiles.com
Source: Simulations Plus, Inc.
FAQ
When is Simulations Plus (SLP) presenting at the KeyBanc Capital Markets Healthcare Forum?
How can investors watch the SLP KeyBanc Healthcare Forum presentation?
How long will the SLP KeyBanc presentation replay be available?
What type of investor meetings is SLP conducting at the KeyBanc Healthcare Forum?
